آرم

Pharmacology, Toxicology and Medical Services

    Dr.Zartab Pic    

Brief introduction:

   First Name: Saman

   Last name: Zartab

   Place of birth: Kermanshah, Iran

   Email address: samanzartab610@yahoo.com, saman.zartab@kums.ac.ir.

  Language skills: English   

  Saman Zartab is graduated from Tehran University of Medical Sciences. He is interested in modelling approaches like regression and neural network models. Also he cooperates with pharmaceutical industry to analyze the pipelines and develop some new products.
Degrees :
  • Ph.D : Pharmacoeconomics and pharmaceutical administration, 2021.
  • Pharm.D : Tehran university of medical sciences, 2011.

Brief Skills and Expertise:

  •  He is working on utility measurement, cost of disease and economic evaluation of new pharmaceutical products.


Recent Interests :

  • Discrete choice experiment
  • drug utilization
  • cost & burden of disease
  • economic evaluation

Last Update : Aug 6, 2023 10:57


Recent Publication :

  • Zartab S, Abbasian H, Hajimolaali M. Despite Affordability, Low Utilization of Lipid Lowering Drugs in Iran: Trend Analysis and Benchmarking 2005-2016. Iranian Journal of Pharmaceutical Research. 2019 May 1;18(2):1117-25.

  • Afzali M, Zartab S, Zaboli P, Nikfar S, Boorboor M. PIN49-THE COST-EFFECTIVENESS ANALYSIS OF ANIDULAFUNGIN VERSUS CASPOFUNGIN FOR CANDIDEMIA AND INVASIVE CANDIDIASIS TREATMENT: AN EXPERIENCE FROM IRAN. Value in Health. 2018 Oct 1;21:S229.

  • Mansoori M, Zaboli P, Saeedi M, Janbabai G, Nikfar S, Rohani E, Zartab S. Evaluation of Health Care Reform Impact on Cancer PatientsAccess To Medicine: A Pilot-Center Experience in Islamic Republic of Iran. Value in Health. 2017 Oct 1;20(9):A879.

  • Al Iami AH, Zartab S, Jaberidoost M, Yektadoost A, Nikfar S, Kebriaeezadeh A. Iranian Pharmaceutical Industry Opportunities in Iraq. Journal of Pharmacoeconomics and Pharmaceutical Management. 2017; 3(3/4):35-40.

  • Kebriaee-zadeh A, Zartab S, Fatemi F, Radmanesh R. 2013. Fundamentals and Stock Return in Pharmaceutical companies: a Panel Data model of Iranian Industry. Iranian Journal of Pharmaceutical Sciences. 9(1), 55-60.

  • Abbassian H, Hajimolaali M, Yektadoost A , Zartab S*,Antibiotic overconsumption in Iran 2000-2016: pattern analysis and benchmarking with OECD countries. Journal of research in pharmacy practice. 2019; 8(3): 162-167

  • Khedmati J, Soleymani F, Moosivand A, Zartab S, Seyedifar M. Economic Evaluation for Benign Prostatic Hyperplasia in Iran: Surgical Treatment or Dutasteride. Iranian Journal of Pharmaceutical Research. 2021 Mar 1;20(1):206-15.

  • Zartab S, Nassiri Koopaei N, Abbasian H, Nassiri Koopaei M, Nassiri Koopaei N, The impact of sanction and healthcare system reform on the healthcare performance and pharmaceutical market in Iran; 2001-2016. Journal of Pharmaceutical Policy and Practice. 2020; 13:50

  • Zartab S, Nikfar S, Karimpour-Fard N, Jamshidi A, Varahrami V, Homayouni A, Kebriaeezadeh A. A Systematic Review of Discrete Choice Experiment Studies in Rheumatoid Arthritis Biological Medicines. Mediterr J Rheumatol 2020;32(2):104-11

 

google scholar link :

https://scholar.google.com/citations?user=pQyBXcUAAAAJ&hl=en


Contact Information :

        Tel : 083-34266780, 287

 Work Email : samanzartab610@yahoo.com

Work Fax : 083-34276493

Work Address : Department of pharmacology, Pharmacy school, Kermanshah.